AAAAAA
Results:
1-11
|
Results: 11
Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)
Authors:
Scheja, A
Akesson, A
Geborek, P
Wildt, M
Wollheim, CB
Wollheim, FA
Vischer, UM
Citation: A. Scheja et al., Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma), ARTHRITIS R, 3(3), 2001, pp. 178-NIL_1
Authors:
Burggraaf, J
Lalezari, S
Emeis, JJ
Vischer, UM
de Meyer, PHEM
Pijl, H
Cohen, AF
Citation: J. Burggraaf et al., Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol, THYROID, 11(2), 2001, pp. 153-160
Authors:
Vischer, UM
Barth, H
Wollheim, CB
Citation: Um. Vischer et al., Regulated von Willebrand factor secretion is associated with agonist-specific patterns of cytoskeletal remodeling in cultured endothelial cells, ART THROM V, 20(3), 2000, pp. 883-891
Authors:
Kobayashi, T
Vischer, UM
Rosnoblet, C
Lebrand, C
Lindsay, M
Parton, RG
Kruithof, EKO
Gruenberg, J
Citation: T. Kobayashi et al., The tetraspanin CD63/lamp3 cycles between endocytic and secretory compartments in human endothelial cells, MOL BIOL CE, 11(5), 2000, pp. 1829-1843
Authors:
Rosnoblet, C
Ribba, AS
Wollheim, CB
Kruithof, EKO
Vischer, UM
Citation: C. Rosnoblet et al., Regulated von Willebrand factor (vWf) secretion is restored by pro-vWf expression in a transfectable endothelial cell line, BBA-MOL CEL, 1495(1), 2000, pp. 112-119
Authors:
Kaufmann, JE
Oksche, A
Wollheim, CB
Gunther, G
Rosenthal, W
Vischer, UM
Citation: Je. Kaufmann et al., Vasopressin-induced von Willebrand factor secretion from endothelial cellsinvolves V2 receptors and cAMP, J CLIN INV, 106(1), 2000, pp. 107-116
Authors:
Rosnoblet, C
Vischer, UM
Gerard, RD
Irminger, JC
Halban, PA
Kruithof, EKO
Citation: C. Rosnoblet et al., Storage of tissue-type plasminogen activator in Weibel-Palade bodies of human endothelial cells, ART THROM V, 19(7), 1999, pp. 1796-1803
Authors:
Vischer, UM
de Moerloose, P
Citation: Um. Vischer et P. De Moerloose, von Willebrand factor: from cell biology to the clinical management of vonWillebrand's disease, CR R ONC H, 30(2), 1999, pp. 93-109
Authors:
Vischer, UM
Citation: Um. Vischer, Hyperglycemia and the pathogenesis of atherosclerosis: lessons from murinemodels, EUR J ENDOC, 140(1), 1999, pp. 1-3
Authors:
van Baal, WM
Kenemans, P
Emeis, JJ
Schalkwijk, CG
Mijatovic, V
van der Mooren, MJ
Vischer, UM
Stehouwer, CDA
Citation: Wm. Van Baal et al., Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women, FERT STERIL, 71(4), 1999, pp. 663-670
Authors:
Vischer, UM
Emeis, JJ
Bilo, HJG
Stehouwer, CDA
Thomsen, C
Rasmussen, O
Hermansen, K
Wollheim, CB
Ingerslev, J
Citation: Um. Vischer et al., vonWillebrand factor (vWf) as a plasma marker of endothelial activation indiabetes: Improved reliability with parallel determination of the vWf propeptide (vWf : AgII), THROMB HAEM, 80(6), 1998, pp. 1002-1007
Risultati:
1-11
|